Ling Zhen
Chief Executive Officer bei Fountain Medical Development Ltd.
Profil
Ling Zhen is currently the Co-Chairman & Chief Executive Officer at Fountain Medical Development Ltd.
Prior to this, Mr. Zhen worked as an Independent Non-Executive Director at China Health Group, Inc. from 2018 to 2023.
Mr. Zhen has a graduate degree from North Carolina Central University, an undergraduate degree from the University of Science & Technology of China, and an MBA from Kelley School of Business.
Aktive Positionen von Ling Zhen
| Unternehmen | Position | Beginn |
|---|---|---|
Fountain Medical Development Ltd.
 Fountain Medical Development Ltd. BiotechnologyHealth Technology Part of ClinChoice Medical (TIANJIN) Co., Ltd., Fountain Medical Development Ltd. is a clinical CRO that provides one-stop services for biomedical and medical equipment customers. Clinchoice has been accelerating drug and device approvals to market for more than 25 years and offers services such as project management, clinical operations, biological statistics, data management, registered affairs, medical affairs, and drug warning. The quality service runs through every link of the Clinchoice Kunyu service, and the quality assurance team is an independent team that focuses on the construction and continuous improvement of the American company's internal quality management system. The private company was founded by Dan Zhang and Ling Zhen has been the CEO of the company since 2020. Laibiyi was founded in 2016 and is committed to solving the pain points of clinical research through in-depth cooperation with hospitals and a clinical research center that builds standardized standards. In 2021, Clinchoice Kunzhe acquired Laibiyi Technology (Xiamen) Co., Ltd. to further improve its phase I clinical trial platform. | Chief Executive Officer | 01.01.2020 |
Ehemalige bekannte Positionen von Ling Zhen
| Unternehmen | Position | Ende |
|---|---|---|
| CHINA HEALTH GROUP INC. | Director/Board Member | 21.09.2023 |
Ausbildung von Ling Zhen
| North Carolina Central University | Graduate Degree |
| University of Science & Technology of China | Undergraduate Degree |
| Kelley School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| CHINA HEALTH GROUP INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Fountain Medical Development Ltd.
Fountain Medical Development Ltd. BiotechnologyHealth Technology Part of ClinChoice Medical (TIANJIN) Co., Ltd., Fountain Medical Development Ltd. is a clinical CRO that provides one-stop services for biomedical and medical equipment customers. Clinchoice has been accelerating drug and device approvals to market for more than 25 years and offers services such as project management, clinical operations, biological statistics, data management, registered affairs, medical affairs, and drug warning. The quality service runs through every link of the Clinchoice Kunyu service, and the quality assurance team is an independent team that focuses on the construction and continuous improvement of the American company's internal quality management system. The private company was founded by Dan Zhang and Ling Zhen has been the CEO of the company since 2020. Laibiyi was founded in 2016 and is committed to solving the pain points of clinical research through in-depth cooperation with hospitals and a clinical research center that builds standardized standards. In 2021, Clinchoice Kunzhe acquired Laibiyi Technology (Xiamen) Co., Ltd. to further improve its phase I clinical trial platform. | Health Technology |
